BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 23177279)

  • 1. The epidemiology of chronic hepatitis C and one-time hepatitis C virus testing of persons born during 1945 to 1965 in the United States.
    Ward JW
    Clin Liver Dis; 2013 Feb; 17(1):1-11. PubMed ID: 23177279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.
    Smith BD; Morgan RL; Beckett GA; Falck-Ytter Y; Holtzman D; Teo CG; Jewett A; Baack B; Rein DB; Patel N; Alter M; Yartel A; Ward JW;
    MMWR Recomm Rep; 2012 Aug; 61(RR-4):1-32. PubMed ID: 22895429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of timing and prioritization on the cost-effectiveness of birth cohort testing and treatment for hepatitis C virus in the United States.
    McEwan P; Ward T; Yuan Y; Kim R; L'italien G
    Hepatology; 2013 Jul; 58(1):54-64. PubMed ID: 23389841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.
    Alter MJ; Kruszon-Moran D; Nainan OV; McQuillan GM; Gao F; Moyer LA; Kaslow RA; Margolis HS
    N Engl J Med; 1999 Aug; 341(8):556-62. PubMed ID: 10451460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010.
    Ditah I; Ditah F; Devaki P; Ewelukwa O; Ditah C; Njei B; Luma HN; Charlton M
    J Hepatol; 2014 Apr; 60(4):691-8. PubMed ID: 24291324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Projecting future complications of chronic hepatitis C in the United States.
    Davis GL; Albright JE; Cook SF; Rosenberg DM
    Liver Transpl; 2003 Apr; 9(4):331-8. PubMed ID: 12682882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changing epidemiology and natural history of hepatitis C virus infection.
    Bialek SR; Terrault NA
    Clin Liver Dis; 2006 Nov; 10(4):697-715. PubMed ID: 17164113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection.
    Jacobson IM; Davis GL; El-Serag H; Negro F; Trépo C
    Clin Gastroenterol Hepatol; 2010 Nov; 8(11):924-33; quiz e117. PubMed ID: 20713178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management.
    Verucchi G; Calza L; Manfredi R; Chiodo F
    Infection; 2004 Feb; 32(1):33-46. PubMed ID: 15007741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis Outreach Network: a practical strategy for hepatitis screening with linkage to care in foreign-born communities.
    Perumalswami PV; Factor SH; Kapelusznik L; Friedman SL; Pan CQ; Chang C; Di Clemente F; Dieterich DT
    J Hepatol; 2013 May; 58(5):890-7. PubMed ID: 23333446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States.
    Nainan OV; Alter MJ; Kruszon-Moran D; Gao FX; Xia G; McQuillan G; Margolis HS
    Gastroenterology; 2006 Aug; 131(2):478-84. PubMed ID: 16890602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of hepatitis C virus infection in American veterans.
    Cheung RC
    Am J Gastroenterol; 2000 Mar; 95(3):740-7. PubMed ID: 10710068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C in Arkansas: updates on epidemiology, testing and treatment.
    Beebe A; Quattlebaum T; Gicquelais RE; Zohoori N; Haselow DT; Smith NH; Patil N
    J Ark Med Soc; 2015 May; 111(12):248-51. PubMed ID: 25966598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention and treatment of hepatitis C in illicit drug users].
    Sakoman S
    Acta Med Croatica; 2009 Dec; 63(5):437-42. PubMed ID: 20198904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-based hepatitis C surveillance and treatment in a national managed care organization.
    Shatin D; Schech SD; Patel K; McHutchison JG
    Am J Manag Care; 2004 Apr; 10(4):250-6. PubMed ID: 15124501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and management of chronic hepatitis C virus infection in women.
    Beste LA; Bondurant HC; Ioannou GN
    Med Clin North Am; 2015 May; 99(3):575-86. PubMed ID: 25841601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology of hepatitis C in Germany].
    Niederau C; Kapagiannidis C
    Med Klin (Munich); 2006 Jun; 101(6):448-57. PubMed ID: 16767568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of gallbladder disease among persons with hepatitis C virus infection in the United States.
    Bini EJ; McGready J
    Hepatology; 2005 May; 41(5):1029-36. PubMed ID: 15770666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Clinical Management of Persons with Chronic Hepatitis C Virus Infection - Cherokee Nation, 2012-2015.
    Mera J; Vellozzi C; Hariri S; Carabin H; Drevets DA; Miller A; Reilley B; Essex W; Gahn D; Lyons L; Leston J; Ward JW
    MMWR Morb Mortal Wkly Rep; 2016 May; 65(18):461-6. PubMed ID: 27172175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.